logo

Scandinavian Formulas, Inc. is the exclusive, worldwide supplier of Sodium Phenylbutyrate under the trademark SPB11™ which has been used in clinical studies since 1987 and is now supplied as a generic drug to treat Urea Cycle Disorder.

Scandinavian Formulas, Inc. is the exclusive, worldwide supplier of Sodium Phenylbutyrate under the trademark SPB11™ which has been used in clinical studies since 1987 and is now supplied as a generic drug to treat Urea Cycle Disorder.

Sodium Phenylbutyrate has been and is being studied for use in the treatment of diseases such as cancer, cystic fibrosis, sickle cell anemia, ALS, Parkinson’s disease, glaucoma, spinal muscular atrophy, AIDS, tuberculosis, and others.

In addition to supplying Sodium Phenylbutyrate as an Active Pharmaceutical Ingredient (API), Scandinavian Formulas can assist with the development of various dosing formulations, streamlining all stages of development to include technical and regulatory support.

Click this link to download a list of references for various studies

Copies of clinical studies are available upon request.